[Diagnosis and treatment of hemophagocytic syndrome].
Kawa
Keisei
K
Sakata
Akifumi
A
Takeshita
Yasufumi
Y
Inoue
Masami
M
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D016207:Cytokines / Q000097:blood; D003907:Dexamethasone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005047:Etoposide / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D051359:Lymphohistiocytosis, Hemophagocytic / Q000145:classification / Q000175:diagnosis* / Q000276:immunology / Q000628:therapy*; D008264:Macrophages / Q000276:immunology; D010951:Plasma Exchange; D012720:Severity of Illness Index; D013601:T-Lymphocytes / Q000276:immunology
D000893:Anti-Inflammatory Agents; D000972:Antineoplastic Agents, Phytogenic; D016207:Cytokines; D007166:Immunosuppressive Agents; D005047:Etoposide; D003907:Dexamethasone; D016572:Cyclosporine